Global University Venturing

Analysis: Q2 2019

The latest note by data provider PitchBook found that, in the context of growth in corporate venture capital, the most active CVC arms it examines have shown a strong historical performance and corporate-backed portfolio companies have reaped benefits in the form of higher exit chances and lower bankruptcy rates

Innovative region: Switzerland

It has been a remarkable decade for innovation capital. More than $1 trillion of venture capital had been invested by the end of last year, according to data provider Pitchbook, driven by corporations engaging in more than half that total, according to GCV Analytics.

Sector Analysis: Information Technology

Monthly analysis: June 2019

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

MedaRed is targeting a blood-clotting factor called fibrin linked to neuron-toxic inflammation in diseases including Alzheimer’s, based on the work of Katerina Akassoglou at UCSF’s School of Medicine.

Two state-run initiatives targeting publicly-funded research have awarded $17.5m to programs including University of Auckland’s commercialisation arm, as New Zealand continues its bid to bring national R&D spend to 2% of GDP over the next decade.

Armed with findings from University of Oxford's Department of Zoology, Blue Water Vaccines believes it has the blueprint for a universal influenza vaccine.

The deadline for Roche’s $4.3bn purchase of CHOP's gene therapy developer Spark has been postponed until April 2020 amid regulatory scrutiny and pending lawsuits.